EMJ Oncology 10 [Supplement 8] . 2022

In this issue

EMJ had the pleasure of interviewing two leading specialists within the field of oncology and oesophageal cancer, Zachary Wilmer Reichenbach, Department of Gastroenterology, Section of Medicine, and the Center for Substance Abuse Research (CSAR), Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA, and Elizabeth Smyth, Cambridge University Hospitals NHS Foundation Trust, UK. The experts shared their perspectives on the treatment landscape of oesophageal cancer.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.